The profitability of REGAL REXNORD CORP over the past 10 years
Chart REGAL REXNORD CORP: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →REGAL REXNORD CORP reported net income of $279.5M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $2.22B and operating income of $680.8M. It reported a profit in 9 of the 10 years shown, and a loss in fiscal 2023. Its highest net income in these years was $488.9M, in fiscal 2022.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.22B | $680.8M | $279.5M |
| 2024ended Dec 31, 2024 | $2.19B | $630M | $196.2M |
| 2023ended Dec 31, 2023 | $2.07B | $377.1M | -$57.4M |
| 2022ended Dec 31, 2022 | $1.67B | $690.4M | $488.9M |
| 2021ended Jan 1, 2022 | $1.11B | $358.3M | $229.6M |
| 2020ended Jan 2, 2021 | $806.6M | $278M | $187.7M |
| 2019ended Dec 28, 2019 | $860.7M | $351.1M | $238.9M |
| 2018ended Dec 29, 2018 | $964.6M | $347M | $231.2M |
| 2017ended Dec 30, 2017 | $883.6M | $331.1M | $213M |
| 2016ended Dec 31, 2016 | $865M | $322.5M | $203.4M |
Fiscal years as REGAL REXNORD CORP reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGAL REXNORD CORP
- The revenue of REGAL REXNORD CORP
- The cash flow of REGAL REXNORD CORP
- The debt of REGAL REXNORD CORP
- The dividends of REGAL REXNORD CORP
- All of REGAL REXNORD CORP's financials, charted
Companies of a similar size
- MUSAMURPHY USA INC.
- PTGXProtagonist Therapeutics, Inc
- BXPBXP, INC.
- NTSKNetskope, Inc.
- BIOBIO-RAD LABORATORIES, INC.
Not investment advice. This page shows what REGAL REXNORD CORP filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.